Home / Pharmaceutical company intelligence
Shaigan Pharmaceuticals (Pvt) Ltd logo
Pharmaceutical company intelligence

Shaigan Pharmaceuticals (Pvt) Ltd

Private pharmaceutical manufacturer · Rawalpindi · Pakistan

Rawalpindi-based pharmaceutical manufacturer focused on branded generic medicines, quality systems and international market expansion.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date18 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Shaigan Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
14-km, Adyala Road, Post Office Dahgal, Rawalpindi, Pakistan
Phone
+92 51 5133060-8
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000333 Shaigan Pharmaceutical (Pvt) Ltd. · Punjab
Semi Basic Manufacture 000984 Shaigan Pharmaceutical (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000333 199 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx210public portfolio records represented
REG150unique registrations represented
IDX105indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR198current validated price records
G74generic molecules in indexed catalogue
DF13dosage-form groups
TA17therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage94%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage90%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixShaigan Pharmaceuticals (Pvt) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/shaigan-pharmaceuticals-pvt-ltdGenerated 24 Sep 2026Anti-infectives105 · 53%Reproductive & genitourinary13 · 7%Hematology & thrombosis13 · 7%Cardiovascular11 · 6%Endocrine & metabolic10 · 5%Gastrointestinal & hepatology9 · 5%Vitamins, minerals & nutrition8 · 4%Other therapeutic areas29 · 15%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioShaigan Pharmaceuticals (Pvt) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/shaigan-pharmaceuticals-pvt-ltdGenerated 24 Sep 2026198presentationsTablet92 · 46%Injection54 · 27%Capsule15 · 8%Cream12 · 6%Syrup10 · 5%Suspension5 · 3%Other forms10 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionShaigan Pharmaceuticals (Pvt) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/shaigan-pharmaceuticals-pvt-ltdGenerated 24 Sep 2026179comparable productsBelow peer median74 · 41%Near peer median37 · 21%Above peer median68 · 38%Company median price position+0.0%Lowest-price equivalents16Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsShaigan Pharmaceuticals (Pvt) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/shaigan-pharmaceuticals-pvt-ltdGenerated 24 Sep 2026Nabiqasim Industries (Pvt) Ltd.,43 shared58% overlapTABROS PHARMA (PVT). LTD.37 shared50% overlapPharmasol (Pvt) Ltd.36 shared49% overlapCCL Pharmaceuticals (Pvt.) Limited36 shared49% overlapValor Pharmaceuticals36 shared49% overlapNeutro Pharma (Pvt.) Ltd.,36 shared49% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives105 products · 53%
Reproductive & genitourinary13 products · 7%
Hematology & thrombosis13 products · 7%
Cardiovascular11 products · 6%
Endocrine & metabolic10 products · 5%
Gastrointestinal & hepatology9 products · 5%
Vitamins, minerals & nutrition8 products · 4%
Respiratory & allergy7 products · 4%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins42 products · 21%
Antivirals13 products · 7%
Anticoagulants10 products · 5%
Antiparasitic medicines10 products · 5%
Antifungals9 products · 5%
Antidiabetic medicines9 products · 5%
Antimalarials9 products · 5%
Vitamins / minerals / hematinics8 products · 4%
Formulation footprint

Dosage forms

Tablet92 products
Injection54 products
Capsule15 products
Cream12 products
Syrup10 products
Suspension5 products
Drops2 products
Gel2 products
Sachet2 products
Lotion1 products
Ointment1 products
Pessary1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 Celtis-1000Ceftriaxone 9presentations 1000 mg · Injection #2 Celtis-250Ceftriaxone 8presentations 250 mg · Injection #3 Celtis-500Ceftriaxone 7presentations 500 mg · Injection #4 SkabPermethrin 7presentations 5% w/w, 50 mg, 50 mg/g · Cream, Lotion #5 BexusLevofloxacin 6presentations 250 mg, 500 mg, 750 mg · Tablet #6 CeltisCeftriaxone 6presentations 1000 mg, 250 mg, 500 mg · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median7441% of comparable products
Near market median37within ±5% of median
Above market median6838% of comparable products
Lowest-price equivalents16ties included
Company median price position +0.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Sygate 0.3 mgConjugated estrogens · Tablet · 30's PKR 3.72/tablet-89.9% vs market median Embex 10 mgRivaroxaban · Tablet · 4x7's PKR 67.23/tablet-87.8% vs market median Embex 10 mgRivaroxaban · Tablet · 10's PKR 70.03/tablet-87.3% vs market median Embex DS 20 mgRivaroxaban · Tablet · 4x7's PKR 118.65/tablet-86.7% vs market median Embex Forte 15 mgRivaroxaban · Tablet · 4x7's PKR 94.92/tablet-86.5% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 43shared generics TABROS PHARMA (PVT). LTD.179 products · 65 generics 37shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 36shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 36shared generics Valor Pharmaceuticals219 products · 97 generics 36shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 36shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers140Distinct registrations among indexed, published, presentation-validated products only
Verified price observations378
Products with a verified price198
Products with multiple price observations180
Source records with multiple versions198
Latest portfolio source check22 Sep 2026
Latest effective price date18 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

150 unique registration(s) · 105 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Clozox Clotrimazole 100 mg Tablet 6's 025941 PKR 170.89 PKR 28.48/tablet 38% above median
Clozox Clotrimazole 500 mg Tablet 1's 025942 PKR 144.30 PKR 144.30/tablet 19% above median
Clozox Clotrimazole 2% Vaginal cream 35gm 025944 PKR 180.67 PKR 5.16/g 61% above median
Clozox Clotrimazole 10 mg Cream 10gm 051098 PKR 127.96 PKR 12.80/g 96% above median
Declawin Daclatasvir 60 mg Tablet 28's 098355 PKR 8,405.66 PKR 300.20/tablet 7% below median
Doxycap Doxycycline 100 mg Capsule 60's 025940 PKR 558.06 PKR 9.30/capsule 18% above median
Doxycap Doxycycline 100 mg Capsule 10's 025940 PKR 95.65 PKR 9.57/capsule 22% above median
Doxycap Doxycycline 100 mg Capsule 10x10's 025940 PKR 785.79 PKR 7.86/capsule Near median
Glykin Amikacin 500 mg Injection 2ml x1's 054492 PKR 262.33 PKR 131.17/mL 8% above median
Glykin Amikacin 250 mg Injection 2ml x1's 054493 PKR 140.76 PKR 70.38/mL 7% above median
Glykin Amikacin 100 mg Injection 2ml x1's 054494 PKR 87.44 PKR 43.72/mL Near median
Gravido Oseltamivir 75 mg Capsule 10's 103368 PKR 1,384.94 PKR 138.49/capsule 15% above median
Hyvex Hydroxychloroquine 200 mg Tablet 30's 084304 PKR 556.15 PKR 18.54/tablet 28% above median
Melofen Sulfadoxine + Pyrimethamine + Mefloquine 500.0 mg + 25.0 mg + 274.0 mg Tablet 30's 018667 PKR 1,776.60 PKR 59.22/tablet No comparator
Melofin Sulfadoxine + Pyrimethamine 500 mg + 25 mg Tablet 3's 025945 PKR 19.19 PKR 6.40/tablet 32% below median
Melofin Sulfadoxine + Pyrimethamine 500 mg + 25 mg Tablet 10's 025945 PKR 81.04 PKR 8.10/tablet 14% below median
Mesan Niclosamide 500 mg Tablet 4's 018668 PKR 64.23 PKR 16.06/tablet No comparator
Micasept Oral Miconazole 20 mg/g Gel 20gm 081676 PKR 180.18 PKR 9.01/g 7% above median
Micasept Topical Miconazole 20 mg/g Cream 20gm 081677 PKR 107.97 PKR 5.40/g 32% below median
Mionex Moxifloxacin 400 mg Tablet 5's 049130 PKR 994.58 PKR 198.92/tablet 8% above median
Riba Ribavirin 400 mg Capsule 10's 038361 PKR 681.55 PKR 68.16/capsule 19% above median
Riba-600 Ribavirin 600 mg Capsule 10's 038362 PKR 1,569.63 PKR 156.96/capsule 77% above median
Romycin Clarithromycin 250 mg Tablet 1x10's 129739 PKR 259.76 PKR 25.98/tablet 45% below median
Romycin Clarithromycin 500 mg Tablet 1x10's 129740 PKR 432.94 PKR 43.29/tablet 48% below median
Ruvar 200 Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 106253 PKR 11,525.21 PKR 96.04/tablet Near median
Ruwin Cefixime 100 mg/5 mL Suspension 30 ml 075354 PKR 330.39 PKR 11.01/mL Near median
Ruwin Cefixime 200 mg/5 mL Dry suspension 30 ml 075355 PKR 404.32 PKR 13.48/mL Near median
Ruwin Cefixime 400 mg Capsule 5x10's 090286 PKR 5,000.18 PKR 100.00/capsule 11% below median
Ruwin Cefixime 400 mg Capsule 2x5's 090286 PKR 1,136.71 PKR 113.67/capsule Near median
Ruwin Cefixime 400 mg Capsule 5's 090286 PKR 592.04 PKR 118.41/capsule Near median
Ruwin Cefixime 200 mg Capsule 1 x 5's 097601 PKR 366.69 PKR 73.34/capsule 17% above median
Skab Permethrin 5% w/w Cream 90gm 051099 PKR 275.90 PKR 3.07/g 25% below median
Skab Permethrin 50 mg/g Cream 60gm 051099 PKR 187.77 PKR 3.13/g 11% below median
Skab Permethrin 5% w/w Cream 30gm 051099 PKR 122.76 PKR 4.09/g 31% above median
Skab Permethrin 5% w/w Cream 40gm 051099 PKR 125.17 PKR 3.13/g 24% below median
Skab Permethrin 50 mg Lotion 120ml 051197 PKR 327.57 PKR 2.73/mL Near median
Skab Permethrin 50 mg/g Cream 90ml 051197 PKR 250.80 PKR 2.79/mL Near median
Skab Permethrin 50 mg/g Cream 60ml 051197 PKR 170.62 PKR 2.84/mL Near median
Sporay Itraconazole 100 mg Capsule 4's 051174 PKR 648.67 PKR 162.17/capsule 12% above median
Temprin Artemether + Lumefantrine 240 mg + 240 mg Tablet 8's 075356 PKR 563.04 PKR 70.38/tablet 8% above median
Temprin Artemether + Lumefantrine 240 mg + 240 mg Tablet 6x8's 075356 PKR 2,853.08 PKR 59.44/tablet 11% below median
Temprin Artemether + Lumefantrine 20 mg + 120 mg Tablet 2x8 085372 PKR 542.56 PKR 33.91/tablet 15% below median
Temprin Plus Artemether + Lumefantrine 80 mg + 480 mg Tablet 6's 075357 PKR 703.80 PKR 117.30/tablet 8% above median
Temprin Plus Artemether + Lumefantrine 80 mg + 480 mg Tablet 4's 075357 PKR 469.20 PKR 117.30/tablet 8% above median
Ternifer Terbinafine 1 % Cream 10gm 109369 PKR 237.33 PKR 23.73/g 19% below median
Ternifer Terbinafine 1 % Gel 10gm 109370 PKR 237.33 PKR 23.73/g 20% above median
Ticavir Entecavir 0.5 mg Tablet 3x10's 063199 PKR 18,844.91 PKR 628.16/tablet 76% above median
Ticavir Entecavir 1 mg Tablet 30's 072007 PKR 22,613.82 PKR 753.79/tablet 31% above median
Vebuvir Sofosbuvir 400 mg Tablet 28's 094329 PKR 11,704.88 PKR 418.03/tablet Near median
Vebuvir-L 400mg Sofosbuvir 400 mg Tablet 28's 099566 PKR 54,289.61 PKR 1,938.91/tablet 354% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Shaigan Pharmaceuticals (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/shaigan-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.